Eitan Yaron receives 75,000 RSUs at Marpai; beneficial ownership now 1.54M
Rhea-AI Filing Summary
Marpai, Inc. (MRAI) director Eitan Yaron acquired 75,000 restricted stock units (RSUs) on 08/19/2025 under a grant that vests in three equal tranches over nine months. The filing reports these RSUs were recorded at $0 price and, after the grant, Mr. Yaron beneficially owns 1,542,527 shares. The Form 4 indicates the reporting person is a director and the transaction was a non-derivative acquisition of Class A common stock RSUs.
Positive
- Director increased equity stake via a 75,000 RSU grant, bringing beneficial ownership to 1,542,527 shares
- Time-based vesting (25,000 RSUs at 3, 6 and 9 months) aligns director incentives with shareholder value over the near term
- Form 4 filed and signed, indicating compliance with Section 16 reporting obligations
Negative
- None.
Insights
TL;DR: Director received 75,000 RSUs vesting over nine months, raising beneficial ownership to 1.54M shares.
The acquisition is a typical compensation-related grant recorded as non-derivative RSUs with a stated price of $0 and scheduled vesting of 25,000 RSUs at three, six and nine months from grant. For investors, this signals continued equity-based compensation for a director rather than open-market buying or selling. The increase to 1,542,527 shares is material to insider ownership disclosures but the filing includes no cash transaction, option exercise or sale activity to affect liquidity or float.
TL;DR: Governance-wise, this is a standard director compensation grant with time-based vesting; no red flags in the filing.
The Form 4 identifies the reporting person as a director and documents a time-based RSU award vesting in three tranches over nine months. The signature date is 09/15/2025 and the transaction date is 08/19/2025. There is no indication of a Rule 10b5-1 plan or of accelerated vesting, related-party transactions, or exercises that would raise governance concerns. Disclosure appears routine and compliant with Section 16 filing requirements.